Philips v. Haemonetics: Intravascular Pressure Sensor Patent Case Dismissed With Prejudice
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Koninklijke Philips N.V. et al. v. Haemonetics Corporation et al. |
| Case Number | 1:24-cv-00206 (D. Del.) |
| Court | U.S. District Court for the District of Delaware |
| Duration | Feb 2024 – Sep 2025 568 days |
| Outcome | Dismissed With Prejudice (Stipulated) |
| Patents at Issue | |
| Accused Products | XTender, SavvyWire, OptoWire series, OptoMonitor, and other intravascular measurement and monitoring platforms. |
Case Overview
The Parties
⚖️ Plaintiff
Global health technology leader with an extensive IP portfolio in diagnostic imaging and interventional cardiology, co-asserting rights with IP2IPO Innovations, Ltd.
🛡️ Defendant
Publicly traded medical technology company that acquired OpSens Inc., now a major competitor in cardiovascular pressure sensing products.
Patents at Issue
This case involved U.S. Patent No. 10,912,463 B2, covering methods and systems related to intravascular pressure measurement, specifically the computation of **Diastolic Pressure Ratio (dPR)**.
- • US 10,912,463 B2 — Diastolic Pressure Ratio (dPR) computation for coronary artery stenosis assessment.
Developing a similar medical device?
Check if your cardiovascular pressure sensor technology might infringe this or related patents.
The Verdict & Legal Analysis
Outcome
The case closed via **stipulated dismissal with prejudice** on September 5, 2025. All claims and causes of action between the parties are permanently extinguished. Critically, each party bears its own attorneys’ fees, costs, and expenses, indicating no fee-shifting or damages award in either direction.
Verdict Cause Analysis
The dismissal with prejudice, agreed to by both sides without a judicial determination on validity or infringement, is characteristic of a confidential settlement. Influencing factors likely included claim scope uncertainty surrounding dPR computation patents, Haemonetics’ commercial integration of OpSens making an injunction highly disruptive, and Philips’ licensing-oriented enforcement strategy.
Drafting medical device patents?
Learn from this case. Use AI to draft stronger claims that can withstand medtech litigation.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ FTO Analysis for Cardiovascular Devices
This case highlights critical IP risks in intravascular pressure measurement. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications for cardiovascular device innovation.
- View Philips’ full dPR patent family
- Identify key competitors in pressure wire technology
- Analyze claim construction patterns for diagnostic patents
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own cardiovascular device or method.
- Input your device description or method steps
- AI identifies potentially blocking medtech patents
- Get actionable risk assessment report
High Risk Area
dPR and resting index computation methods
Philips’ Patent Family
Actively asserted in this space
Strategic Takeaways
Early FTO critical for system-level IP
✅ Key Takeaways
For Patent Attorneys & Litigators
Stipulated dismissals with prejudice in Delaware often signal confidential licensing resolutions; prepare for Markman to maximize leverage.
Search related case law →Chief Judge Connolly’s court demands rigorous standing and funding disclosures; joint plaintiffs require unified litigation authority agreements.
Explore precedents →For IP Professionals & R&D Leaders
Intravascular pressure computation methods — including dPR, iFR, and resting indices — carry active patent risk; FTO analysis must cover method claims, not just hardware.
Start FTO analysis for my product →System-level infringement exposure (guidewire + monitor + software) means full ecosystem review is required before product launch.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.